Arthritis, Psoriatic - 235 Studies Found Status Study Recruiting Study Name: Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis Condition: Psoriatic Arthritis Date: 2015-03-16 Interventions: Biological: Secukinumab Anti IL-17a monoclonal antibody Completed Study Name: Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis Condition: Psoriatic Arthritis Date: 2014-05-15 Interventions: Drug: UCB4940 40 mg Completed Study Name: Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment (WPAI)) Condition: Psoriatic Arthritis Date: 2015-01-30 Completed Study Name: Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy Condition: Arthritis, Psoriatic, Psoriasis Date: 2006-03-14 Recruiting Study Name: A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation Condition: Psoriatic Arthritis Date: 2016-06-21 Interventions: Biological: adalimumab Drug: methotrexate Not yet recruiting Study Name: A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s) Condition: Arthritis, Psoriatic Date: 2017-05-19 Interventions: Drug: Guselkumab Participants Active, not recruiting Study Name: Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis Condition: Psoriatic Arthritis Date: 2013-07-01 Interventions: Drug: Secukinumab Secukinumab is a human monoclonal antibody. Monoclonal antibodies are proteins that re Recruiting Study Name: Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis Condition: Psoriatic Arthritis Date: 2012-03-19 Completed Study Name: Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis Condition: Psoriatic Arthritis Date: 2013-08-15 Interventions: Drug: Apremilast 30 mg 30mg of Recruiting Study Name: Efficacy of Golimumab in Combination With Methotrexate (Mtx) Versus Mtx Monotherapy, in Improving Dactylitis, in Mtx naïve Psoriatic Arthritis Patients Condition: Psoriatic Arthritis Date: 2014-02-17 Interventions: Drug: Golimumab Prefilled syri <<< Previous | Next >>>